Morieri ML - Search Results

1

Correction to: Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes.

Morieri ML, Lamacchia O, Manzato E, Giaccari A, Avogaro A; Lipid-Lowering-Relevance Study Group. Morieri ML, et al. Cardiovasc Diabetol. 2022 May 13;21(1):73. doi: 10.1186/s12933-022-01515-7. Cardiovasc Diabetol. 2022. PMID: 35562766 Free PMC article. No abstract available.

2

Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysis.

Ahmad A, Lim LL, Morieri ML, Tam CH, Cheng F, Chikowore T, Dudenhöffer-Pfeifer M, Fitipaldi H, Huang C, Kanbour S, Sarkar S, Koivula RW, Motala AA, Tye SC, Yu G, Zhang Y, Provenzano M, Sherifali D, de Souza R, Tobias DK, Gomez MF, Ma RCW, Mathioudakis NN. Ahmad A, et al. Among authors: morieri ml. medRxiv [Preprint]. 2023 Aug 21:2023.04.26.23289177. doi: 10.1101/2023.04.26.23289177. medRxiv. 2023. PMID: 37162891 Free PMC article. Updated. Preprint.

3

Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness study.

Morieri ML, Rigato M, Frison V, Simioni N, D'Ambrosio M, Tadiotto F, Paccagnella A, Lapolla A, Avogaro A, Fadini GP. Morieri ML, et al. Diabetes Obes Metab. 2019 Nov;21(11):2542-2552. doi: 10.1111/dom.13840. Epub 2019 Aug 12. Diabetes Obes Metab. 2019. PMID: 31364233 Free PMC article.

4

Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study.

Morieri ML, Longato E, Mazzucato M, Di Camillo B, Cocchiglia A, Gubian L, Sparacino G, Avogaro A, Fadini GP, Vigili de Kreutzenberg S. Morieri ML, et al. Cardiovasc Diabetol. 2019 Sep 16;18(1):117. doi: 10.1186/s12933-019-0922-1. Cardiovasc Diabetol. 2019. PMID: 31526380 Free PMC article.

5

Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast Italy.

Fadini GP, Frison V, Rigato M, Morieri ML, Simioni N, Tadiotto F, D'Ambrosio M, Paccagnella A, Lapolla A, Avogaro A. Fadini GP, et al. Among authors: morieri ml. Acta Diabetol. 2020 Mar;57(3):367-375. doi: 10.1007/s00592-019-01445-z. Epub 2019 Oct 31. Acta Diabetol. 2020. PMID: 31673896

6

Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies.

Morieri ML, Rigato M, Frison V, Simioni N, D'Ambrosio M, Tadiotto F, Paccagnella A, Lapolla A, Avogaro A, Fadini GP. Morieri ML, et al. Metabolism. 2020 May;106:154190. doi: 10.1016/j.metabol.2020.154190. Epub 2020 Feb 25. Metabolism. 2020. PMID: 32109448

7

Prevalence and impact of diabetes among people infected with SARS-CoV-2.

Fadini GP, Morieri ML, Longato E, Avogaro A. Fadini GP, et al. Among authors: morieri ml. J Endocrinol Invest. 2020 Jun;43(6):867-869. doi: 10.1007/s40618-020-01236-2. Epub 2020 Mar 28. J Endocrinol Invest. 2020. PMID: 32222956 Free PMC article. No abstract available.

8

Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients.

Morieri ML, Frison V, Rigato M, D'Ambrosio M, Tadiotto F, Paccagnella A, Simioni N, Lapolla A, Avogaro A, Fadini GP. Morieri ML, et al. J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa204. doi: 10.1210/clinem/dgaa204. J Clin Endocrinol Metab. 2020. PMID: 32301492

9

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy.

Bonora BM, Morieri ML, Avogaro A, Fadini GP. Bonora BM, et al. Among authors: morieri ml. Diabetes Care. 2021 Jan;44(1):e18-e21. doi: 10.2337/dc20-1872. Epub 2020 Oct 30. Diabetes Care. 2021. PMID: 33127611 No abstract available.

10

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.

Morieri ML, Avogaro A, Fadini GP; the DARWIN-T2D Network of the Italian Diabetes Society. Morieri ML, et al. Cardiovasc Diabetol. 2020 Nov 10;19(1):190. doi: 10.1186/s12933-020-01164-8. Cardiovasc Diabetol. 2020. PMID: 33172454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page